Central blood pressure: Current evidence and clinical importance

European Heart Journal

Volumn 35, Issue 26, 2014, Pages

  McEniery, Carmel M ^a   Cockcroft, John R ^b   Roman, Mary J ^c   Franklin, Stanley S ^d   Wilkinson, Ian B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti Hypertensive treatment; Blood pressure; Cardiovascular risk; Central pressure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; INDAPAMIDE PLUS PERINDOPRIL; NITRIC ACID DERIVATIVE; ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE CUFF; BRACHIAL ARTERY; CARDIOVASCULAR RISK; HEART CATHETERIZATION; HUMAN; HYPERTENSION; PRIORITY JOURNAL; REVIEW; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE; TONOMETRY; AORTA; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASES; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RISK ASSESSMENT;

ANTIHYPERTENSIVE AGENTS; AORTA; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; RISK ASSESSMENT; SPHYGMOMANOMETERS;

EID: 84911932134     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht565     Document Type: Review

References (107)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. age-Specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913.
2. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng AT, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FG, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD 3rd, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassebaum N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F, Lalloo R, Lan Q, Lathlean T, Leasher JL, A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380: 2224-2260.
3. Turnbull F. Effects of different blood-Pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet 2003;362:1527-1535.
4. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, Umans JG, Howard BV. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: The Strong Heart Study. Hypertension 2007 50:197-203.
5. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, London GM.Central pulse pressure and mortality in end-Stage renal disease. Hypertension 2002;39:735-738.
6. Pini R, Cavallini MC, Palmieri V, Marchionni N, Di Bari M, Devereux RB, Masotti G, Roman MJ. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: The ICARe Dicomano Study. J Am Coll Cardiol 2008;51:2432-2439.
7. Jankowski P, Kawecka-Jaszcz K, Czarnecka D, Brzozowska-Kiszka M, Styczkiewicz K, Loster M, Kloch-Badelek M, Wilinski J, Curylo AM, Dudek D. Pulsatile but not steady component of blood pressure predicts cardiovascular events in coronary patients. Hypertension 2008;51:848-855.
8. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M. Differential impact of blood pressure-Lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006;113:1213-1225.
9. Asmar RG, London GM, O'Rourke ME, Safar ME. Improvement in blood pressure, arterial stiffness and wave reflections with a very-Low-Dose perindopril/indapamide combination in hypertensive patient: A comparison with atenolol. Hypertension 2001;38:922-926.
10. Wilkinson IB, McEniery CM, Cockcroft JR. Atenolol and cardiovascular risk: An issue close to the heart. Lancet 2006;367:627-629.
11. Kroeker EJ,Wood EH. Comparison of simultaneously recorded central and peripheral arterial pressure pulses during rest, exercise and tilted position in man. Circ Res 1955;3:623-632.
12. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001;38:932-937.
13. Ohte N, Saeki T, Miyabe H, Sakata S, Mukai S, Hayano J, Niki K, Sugawara M, Kimura G. Relationship between blood pressure obtained from the upper arm with a cuff-Type sphygmomanometer and central blood pressure measured with a catheter-Tipped micromanometer. Heart Vessels 2007;22:410-415.
14. NicholsWW, O'Rourke MF. McDonald's Blood Flow in Arteries: Theoretic, Experimental and Clinical Principles. 5th ed., London: Edward Arnold, 2005.
15. Westerhof N, Sipkema P, van den Bos GC, Elzinga G. Forward and backward waves in the arterial system. Cardiovasc Res 1972;6:648-656.
16. Westerhof N, Lankhaar JW,Westerhof BE. The arterial Windkessel. Med Biol Eng Comput 2009;47:131-141.
17. Wang JJ, O'Brien AB, Shrive NG, Parker KH, Tyberg JV. Time-Domain representation of ventricular-arterial coupling as a windkessel and wave system. Am J Physiol Heart Circ Physiol 2003;284:H1358-H1368.
18. Davies JE, Baksi J, Francis DP, Hadjiloizou N, Whinnett ZI, Manisty CH, Aguado-Sierra J, Foale RA, Malik IS, Tyberg JV, Parker KH, Mayet J, Hughes AD. The arterial reservoir pressure increases with aging and is the major determinant of the aortic augmentation index. Am J Physiol Heart Circ Physiol 2010;298: H580-H586.
19. Mynard JP, Penny DJ, Davidson MR, Smolich JJ. The reservoir-wave paradigm introduces error into arterial wave analysis: A computer modelling and in vivo study. J Hypertens 2012;30:734-743.
20. Segers P, Swillens A, Vermeersch S. Reservationson the reservoir. J Hypertens 2012; 30:676-678.
21. Camacho F, Avolio A, Lovell NH. Estimation of pressure pulse amplification between aorta and brachial artery using stepwise multiple regression models. Physiol Meas 2004;25:879-889.
22. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity the anglo-Cardiff collaborative trial (ACCT). J Am Coll Cardiol 2005;46:1753-1760.
23. Wilkinson IB, Mohammad NH, Tyrrell S, Hall IR, Webb DJ, Paul VE, Levy T, Cockcroft JR. Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens 2002;15:24-30.
24. Albaladejo P, Copie X, Boutouyrie P, Laloux B, Declere AD, Smulyan H, Benetos A. Heart rate, arterial stiffness, and wave reflections in paced patients. Hypertension 2001;38:949-952.
25. London GM, Guerin AP, Pannier BM, Marchais SJ, Metivier F. Body height as a determinant of carotid pulse contour in humans. J Hypertens Suppl 1992;10:S93-S95.
26. Kroeker EJ, Wood EH. Beat-To-Beat alterations in relationship of simultaneously recorded central and peripheral arterial pressure pulses during Valsalva maneuver and prolonged expiration in man. J Appl Physiol 1956;8:483-494.
27. McEniery CM, Yasmin, Wallace S, Maki-Petaja K, McDonnell B, Sharman JE, Retallick C, Franklin SS, Brown MJ, Lloyd RC, Cockcroft JR, Wilkinson IB. Increased stroke volume and aortic stiffness contribute to isolated systolic hypertension in young adults. Hypertension 2005;46:221-226.
28. McEniery CM, Yasmin, McDonnell B, Munnery M, Wallace SM, Rowe CV, Cockcroft JR, Wilkinson IB. Central pressure: Variability and impact of cardiovascular risk factors: The Anglo-Cardiff Collaborative Trial II. Hypertension 2008;51: 1476-1482.
29. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A. 2007 ESH-ESC Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press 2007;16:135-232.
30. Van Bortel LM, Balkestein EJ, van der Heijden-Spek JJ, Vanmolkot FH, Staessen JA, Kragten JA, VredeveldJW, Safar ME, Struijker Boudier HA, HoeksAP. Non-invasive assessment of local arterial pulse pressure: Comparison of applanation tonometry and echo-Tracking. J Hypertens 2001;19:1037-1044.
31. O'RourkeMF, Adji A. Noninvasive studies of central aortic pressure. Curr Hypertens Rep 2012;14:8-20.
32. Shih YT, Cheng HM, Sung SH, Hu WC, Chen CH. Quantification of the calibration error in the transfer function-Derived central aortic blood pressures.AmJ Hypertens 2011;24:1312-1317.
33. Verbeke F, Segers P, Heireman S, Vanholder R, Verdonck P, Van Bortel LM. Noninvasive assessment of local pulse pressure: Importance of brachial-To-Radial pressure amplification. Hypertension 2005;46:244-248.
34. Mahieu D, Kips J, Rietzschel ER, De Buyzere ML, Verbeke F, Gillebert TC, De Backer GG, De Bacquer D, Verdonck P, Van Bortel LM, Segers P. Noninvasive assessment of central and peripheral arterial pressure (waveforms): Implications of calibration methods. J Hypertens 2010;28:300-305.
35. MekhailAM, DayLM, Goodhart AK, Wilkinson IB, McEnieryCM.Non-Invasive estimates of central systolic blood pressure: Comparison of the Centron cBP301 and SphygmoCor devices. Artery Res 2012;6:109-113.
36. Climie RE, Schultz MG, Nikolic SB, Ahuja KD, Fell JW, Sharman JE. Validity and reliability of central blood pressure estimated by upper arm oscillometric cuff pressure. Am J Hypertens 2012;25:414-420.
37. Rezai MR, Goudot G, Winters C, Finn JD, Wu FC, Cruickshank JK. Calibration mode influences central blood pressure differences between SphygmoCor and two newer devices, the Arteriograph and Omron HEM-9000. Hypertens Res 2011;34:1046-1051.
38. Pauca AL, Kon ND, O'Rourke MF. The second peak of the radial artery pressure wave represents aortic systolic pressure in hypertensive and elderly patients. Br J Anaesth 2004;92:651-657.
39. Takazawa K, Kobayashi H, Shindo N, Tanaka N, Yamashina A. Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave. Hypertens Res 2007;30:219-228.
40. Guilcher A, Brett S, Munir S, Clapp B, Chowienczyk PJ. Estimating central SBP from the peripheral pulse: Influence of waveform analysis and calibration error. J Hypertens 2011;29:1357-1366.
41. Hickson SS, Butlin M, Mir FA, Graggaber J, Cheriyan J, Khan F, Grace AA, Yasmin, Cockcroft JR, Wilkinson IB, McEniery CM. The accuracy of central SBP determined from the second systolic peak of the peripheral pressure waveform. J Hypertens 2009;27:1784-1788.
42. Sung SH, Cheng HM, Chuang SY, Shih YT, Wang KL, Chen YH, Lin SJ, Yu WC, Chen CH. Measurement of central systolic blood pressure by pulse volume plethysmography with a noninvasive blood pressure monitor. Am J Hypertens 2012;25:542-548.
43. Laurent S, Cockcroft JR, van Bortel LM, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson IB, Struijker Boudier HA. Abridged version of the expert consensus document. Artery Res 2007;1:2-12.
44. Boutouyrie P, Bussy C, Lacolley P, Girerd X, Laloux B, Laurent S. Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation 1999;100:1387-1393.
45. Wang KL, Cheng HM, Chuang SY, Spurgeon HA, Ting CT, Lakatta EG, Yin FC, Chou P, Chen CH. Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality?. J Hypertens 2009;27:461-467.
46. Roman MJ, Okin PM, Kizer JR, Lee ET, Howard BV, Devereux RB. Relations of central and brachial blood pressure to left ventricular hypertrophy and geometry: The Strong Heart Study. J Hypertens 2010;28:384-388.
47. Covic A, Goldsmith DJ, Panaghiu L, Covic M, Sedor J. Analysis of the effect of hemodialysis on peripheral and central arterial pressure waveforms. Kidney Int 2000;57: 2634-2643.
48. de Luca N, Asmar RG, LondonGM, O'Rourke MF, Safar ME. Selective reduction of cardiac mass and central blood pressure on low-Dose combination perindopril/ indapamide in hypertensive subjects. J Hypertens 2004;22:1623-1630.
49. ManistyCH,Zambanini A, Parker KH, Davies JE, FrancisDP,Mayet J,McGThomSA, HughesAD. Differences in the magnitude ofwave reflection account for differential effects of amlodipine- versus atenolol-Based regimens on central blood pressure: An Anglo-Scandinavian Cardiac Outcome Trial substudy. Hypertension 2009;54: 724-730.
50. Boutouyrie P, Bussy C, Hayoz D, Hengstler J, Dartois N, Laloux B, Brunner H, Laurent S. Local pulse pressure and regression of arterial wall hypertrophy during long-Term antihypertensive treatment. Circulation 2000;101:2601-2606.
51. Dart AM, Gatzka CD, Kingwell BA, Willson K, Cameron JD, Liang YL, Berry KL, Wing LM, Reid CM, Ryan P, Beilin LJ, Jennings GL, Johnston CI, McNeil JJ, Macdonald GJ, Morgan TO,West MJ. Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives. Hypertension 2006;47:785-790.
52. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ. Arterial stiffness and cardiovascular events: The Framingham Heart Study. Circulation 2010;121:505-511.
53. Roman MJ, Devereux RB, Kizer JR, Okin PM, Lee ET, Wang W, Umans JG, Calhoun D, Howard BV. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol 2009;54:1730-1734.
54. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-Cause mortality with central haemodynamics: A systematic review and meta-analysis. Eur Heart J 2010;31:1865-1871.
55. Major outcomes in high-risk hypertensive patients randomized to angiotensinconverting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-2997.
56. Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: Is it a wise choice?. Lancet 2004;364:1684-1689.
57. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension?. A Meta-Analysis. Lancet 2005;366: 1545-1553.
58. Medical Research Council trial of treatment of hypertension in older adults: Principal results. MRCWorking Party. BMJ 1992;304:405-412.
59. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S,Wedel H. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 2002;359:995-1003.
60. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial- Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet 2005;366:895-906.
61. Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 2004;17:118-123.
62. Deary AJ, Schumann AL, Murfet H, Haydock S, FooRS, BrownMJ. Influence of drugs and genderonthe arterial pulsewave and natriuretic peptide secretion in untreated patients with essential hypertension. Clin Sci 2002;103:493-499.
63. Mackenzie IS, McEniery CM, Dhakam Z, Brown MJ, Cockcroft JR, Wilkinson IB. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension 2009;54: 409-413.
64. Boutouyrie P, Achouba A, Trunet P, Laurent S. Amlodipine-Valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: The EXPLOR study. Hypertension 2010;55: 1314-1322.
65. Dhakam Z, Yasmin, McEniery CM, Burton T, Brown MJ, Wilkinson IB. A comparison of atenolol and nebivolol in isolated systolic hypertension. J Hypertens 2008;26: 351-356.
66. Kampus P, Serg M, Kals J, Zagura M, Muda P, Karu K, Zilmer M, Eha J. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness. Hypertension 2011;57:1122-1128.
67. Elliott WJ, Childers WK. Should beta blockers no longer be considered first-Line therapy for the treatment of essential hypertension without comorbidities?. Curr Cardiol Rep 2011;13:507-516.
68. Kelly RP, Gibbs HH, O'Rourke MF, Daley JE, Mang K, Morgan JJ, Avolio AP. Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J 1990;11:138-144.
69. Stokes GS, Ryan M. Can Extended-Release Isosorbide Mononitrate be Used as Adjunctive Therapy for Systolic Hypertension? An Open Study Employing Pulse- Wave Analysis to Determine Effects of Antihypertensive Therapy. Am J Geriatr Cardiol 1997;6:11-19.
70. Stokes GS, Bune AJ, Huon N, Barin ES. Long-Term effectiveness of extendedrelease nitrate for the treatment of systolic hypertension. Hypertension 2005;45: 380-384.
71. Stokes GS, Ryan M, Brnabic A, Nyberg G. A controlled study of the effects of isosorbide mononitrate on arterial blood pressure and pulse wave form in systolic hypertension. J Hypertens 1999;17:1767-1773.
72. Duchier J, Iannascoli F, Safar M. Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic systemic hypertension in the elderly. Am J Cardiol 1987;60:99-102.
73. Starmans-Kool MJ, Kleinjans HA, Lustermans FA, Kragten JA, Breed JG, Van Bortel LM. Treatment of elderly patients with isolated systolic hypertension with isosorbide dinitrate in an asymmetric dosing schedule. J Hum Hypertens 1998;12: 557-561.
74. Jiang XJ, O'Rourke MF, Jin WQ, Liu LS, Li CW, Tai PC, Zhang XC, Liu SZ. Quantification of glyceryl trinitrate effect through analysis of the synthesised ascending aortic pressure waveform. Heart 2002;88:143-148.
75. Thomas GR, DiFabio JM, Gori T, Parker JD. Once daily therapy with isosorbide-5- mononitrate causes endothelial dysfunction in humans: Evidence of a free-radical-mediated mechanism. J Am Coll Cardiol 2007;49:1289-1295.
76. Oelze M, Knorr M, Kroller-Schon S, Kossmann S, Gottschlich A, Rummler R, Schuff A, Daub S, Doppler C, Kleinert H, Gori T, Daiber A, Munzel T. Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression. Eur Heart J 2013;34:3206-3216.
77. Richardson CE, Maki-Pataja KM, McDonnell BJ, Hickson SS, Wilkinson IB, McEniery CM. Comparison of estimates of central systolic blood pressure and peripheral augmentation index obtained from theOmron HEM-9000AI and Sphygmo- Cor systems. Artery Res 2009;3:24-32.
78. Kips JG, Schutte AE, Vermeersch SJ, Huisman HW, Van Rooyen JM, Glyn MC, Fourie CM, Malan L, Schutte R, Van Bortel LM, Segers P. Comparison of central pressure estimates obtained from SphygmoCor, Omron HEM-9000AI and carotid applanation tonometry. J Hypertens 2011;29:1115-1120.
79. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J,Webster J. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999;282: 539-546.
80. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E. Prognostic value of ambulatory blood-Pressure recordings in patients with treated hypertension. N Engl J Med 2003;348:2407-2415.
81. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: Follow-Up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005;111: 1777-1783.
82. Huang CM, Wang KL, Cheng HM, Chuang SY, Sung SH, Yu WC, Ting CT, Lakatta EG, Yin FC, Chou P, Chen CH. Central versus ambulatory blood pressure in the prediction of all-Cause and cardiovascular mortalities. J Hypertens 2011;29: 454-459.
83. Schillaci G, Pucci G. Central and 24-h blood pressure: Dwarfs standing upon the shoulders of giants?. J Hypertens 2011;29:430-433.
84. Luzardo L, Lujambio I, Sottolano M, da Rosa A, Thijs L, Noboa O, Staessen JA, Boggia J. 24-h ambulatory recording of aortic pulse wave velocity and central systolic augmentation: A feasibility study. Hypertens Res 2012;35:980-987.
85. Williams B, Lacy PS, Baschiera F, Brunel P, Dusing R. Novel description of the 24-hour circadian rhythms of brachial versus central aortic blood pressure and the impact of blood pressure treatment in a randomized controlled clinical trial: The Ambulatory Central Aortic Pressure (AmCAP) Study. Hypertension 2013;61: 1168-1176.
86. Ott C, Haetinger S, Schneider MP, Pauschinger M, Schmieder RE. Comparison of two noninvasive devices for measurement of central systolic blood pressure with invasive measurement during cardiac catheterization. J Clin Hypertens (Greenwich) 2012;14:575-579.
87. Theilade S, Hansen TW, Joergensen C, Lajer M, Rossing P. Tonometric devices for central aortic systolic pressure measurements in patients with type 1 diabetes: Comparison of the BPro and SphygmoCor devices. Blood Press Monit 2013;18: 156-160.
88. Sharman JE, Lim R, Qasem AM, Coombes JS, Burgess MI, Franco J, Garrahy P, Wilkinson IB, Marwick TH. Validation of a generalized transfer function to noninvasively derive central blood pressure during exercise. Hypertension 2006;47: 1203-1208.
89. Wassertheurer S, Kropf J, Weber T, van der Giet M, Baulmann J, Ammer M, Hametner B, Mayer CC, Eber B, Magometschnigg D. A new oscillometric method for pulse wave analysis: Comparison with a common tonometric method. J Hum Hypertens 2010;24:498-504.
90. Weber T,Wassertheurer S, Rammer M, Maurer E, Hametner B, Mayer CC, Kropf J, Eber B. Validation of a brachial cuff-Based method for estimating central systolic blood pressure. Hypertension 2011;58:825-832.
91. Brett SE, Guilcher A, Clapp B, Chowienczyk P. Estimating central systolic blood pressure during oscillometric determination of blood pressure: Proof of concept and validation by comparison with intra-aortic pressure recording and arterial tonometry. Blood Press Monit 2012;17:132-136.
92. Pucci G, Cheriyan J, Hubsch A, Hickson SS, Gajendragadkar PR, Watson T, O'Sullivan M, Woodcock-Smith J, Schillaci G, Wilkinson IB, McEniery CM. Evaluation of the Vicorder, a novel cuff-Based device for the noninvasive estimation of central blood pressure. J Hypertens 2013;31:77-85.
93. Horvath IG, Nemeth A, Lenkey Z, Alessandri N, Tufano F, Kis P, Gaszner B, Cziraki A. Invasive validation of anewoscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens 2010;28:2068-2075.
94. Lowe A, HarrisonW, El-Aklouk E, Ruygrok P, Al-JumailyAM. Non-Invasive modelbased estimation of aortic pulse pressure using suprasystolic brachial pressure waveforms. J Biomech 2009;42:2111-2115.
95. Hirata K, Vlachopoulos C, Adji A, O'Rourke MF. Benefits from angiotensinconverting enzyme inhibitor 'beyond blood pressure lowering': Beyond blood pressure or beyond the brachial artery?. J Hypertens 2005;23:551-556.
96. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-Stage renal disease. Comparative effects ofACE inhibition and calcium channel blockade. Circulation 1994;90:2786-2796.
97. London GM, Pannier B, Vicaut E, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition. J Hypertens 1996;14:1139-1146.
98. Mitchell GF, Izzo JL Jr, Lacourciere Y, Ouellet JP, Neutel J, Qian C, Kerwin LJ, Block AJ, Pfeffer MA. Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: Results of the conduit hemodynamics of omapatrilat international research study. Circulation 2002;105:2955-2961.
99. Ahimastos AA, Natoli AK, Lawler A, Blombery PA, Kingwell BA. Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture. Hypertension 2005;45:1194-1199.
100. Dart AM, Cameron JD, Gatzka CD, Willson K, Liang YL, Berry KL, Wing LM, Reid CM, Ryan P, Beilin LJ, Jennings GL, Johnston CI, McNeil JJ, Macdonald GJ, Morgan TO,West MJ, Kingwell BA. Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension 2007;49:1242-1247.
101. Aznaouridis KA, Stamatelopoulos KS, Karatzis EN, Protogerou AD, Papamichael CM, Lekakis JP. Acute effects of renin-angiotensin system blockade on arterial function in hypertensive patients. J Hum Hypertens 2007;21:654-663.
102. Jiang XJ, O'Rourke MF, Zhang YQ, He XY, Liu LS. Superior effect of an angiotensinconverting enzyme inhibitor over a diuretic for reducing aortic systolic pressure. J Hypertens 2007;25:1095-1099.
103. Dhakam Z, McEniery CM, Yasmin, Cockcroft JR, Brown MJ, Wilkinson IB. Atenolol and eprosartan: Differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens 2006;19:214-219.
104. Stokes GS, Barin ES, Gilfillan KL. Effects of isosorbidemononitrate and AII inhibition on pulse wave reflection in hypertension. Hypertension 2003;41:297-301.
105. Mahmud A, Feely J. Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension. J Hum Hypertens 2000;14:541-546.
106. Polonia J, Barbosa L, Silva JA, Bertoquini S. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with beta-Blockers either with or without vasodilator properties or with angiotensin receptor blockers. Blood Press Monit 2010;15:235-239.
107. ShahNK, Smith SM, NicholsWW, LoMC,Ashfaq U, Satish P, Johnson JA, Epstein BJ. Carvedilol reduces aortic wave reflection and improves left ventricular/vascular coupling: A comparison with atenolol (CENTRAL Study). J Clin Hypertens (Greenwich) 2011;13:917-924.